Wells Fargo Gives a Buy Rating to Autolus Therapeutics (AUTL)
at www.tipranks.com (Wed, 12-Aug 6:58 AM)
at www.tipranks.com (Wed, 12-Aug 3:40 AM)
AUTL Raises FY26 Guidance as AUCATZYL Revenue Surges 119%—Gross Margins Hit 55% in Q2
Market Chameleon (Tue, 11-Aug 11:19 AM)
Analysts Offer Insights on Healthcare Companies: Autolus Therapeutics (AUTL) and Cronos Group (CRON)
at www.tipranks.com (Tue, 11-Aug 3:00 PM)
at www.tipranks.com (Tue, 11-Aug 1:35 PM)
Wall Street Analysts Are Bullish on Top Healthcare Picks
at www.tipranks.com (Tue, 11-Aug 1:30 PM)
Autolus Lifts 2026 Guidance as AUCATZYL Sales Surge
at www.tipranks.com (Tue, 11-Aug 8:00 AM)
Autolus Therapeutics GAAP EPS of -$0.15 beats by $0.04, revenue of $45.69M beats by $5.54M
at seekingalpha.com (Tue, 11-Aug 7:05 AM)
Here are the major earnings before the open Tuesday
at seekingalpha.com (Mon, 10-Aug 6:00 PM)
Autolus Therapeutics Q2 2026 Earnings Preview
at seekingalpha.com (Mon, 10-Aug 11:00 AM)
Market Chameleon (Mon, 3-Aug 10:31 AM)